ALPHA TAU MEDICAL
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.
ALPHA TAU MEDICAL
Industry:
Health Care Medical Device
Founded:
2016-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.alphatau.com
Total Employee:
51+
Status:
Active
Contact:
+972-3-618-2477
Email Addresses:
[email protected]
Total Funding:
151.71 M USD
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
Accro Bioscience
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Employees Featured
Founder
Stock Details
Investors List
Ronald Cohen
Ronald Cohen investment in Post-IPO Equity - Alpha Tau Medical
Alan Patricof
Alan Patricof investment in Post-IPO Equity - Alpha Tau Medical
OurCrowd
OurCrowd investment in Post-IPO Equity - Alpha Tau Medical
Medison Ventures
Medison Ventures investment in Post-IPO Equity - Alpha Tau Medical
Yozma Group Asia LTD (Yozma Singapore)
Yozma Group Asia LTD (Yozma Singapore) investment in Post-IPO Equity - Alpha Tau Medical
Grand Decade Developments
Grand Decade Developments investment in Post-IPO Equity - Alpha Tau Medical
Regah Ventures
Regah Ventures investment in Post-IPO Equity - Alpha Tau Medical
Shavit Capital
Shavit Capital investment in Series B - Alpha Tau Medical
OurCrowd
OurCrowd investment in Series B - Alpha Tau Medical
Medison Ventures
Medison Ventures investment in Series B - Alpha Tau Medical
Newest Events participated
Official Site Inspections
http://www.alphatau.com Semrush global rank: 7.02 M Semrush visits lastest month: 927
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Alpha Tau Medical"
Alpha Tau Medical - Crunchbase Company Profile & Funding
Alpha Tau Medical may be growing as evidenced by its expansion activities and strategic participation in industry events. The company has entered into a long-term lease for a second …See details»
Alpha Tau Medical | About
Alpha Tau Medical ™ was founded in 2016 by CEO Uzi Sofer to develop and commercialize the Alpha DaRT ™ (Diffusing Alpha-emitters Radiation Therapy), invented by Professors Itzhak Kelson and Yona Keisari from Tel Aviv …See details»
Alpha Tau Medical - LinkedIn
Alpha Tau Medical announced that CFO Raphi Levy will participate in the Citi 2024 Global Healthcare Conference on December 3rd, 2024 and the Piper Sandler 36th Annual …See details»
Alpha Tau Medical - LinkedIn
Alpha Tau Medical is in the house! Our #ASTRO2024 Dream Team, has just arrived and set up our booth (#409), eager to connect again with the world's leading #radiationoncologists.In the …See details»
Alpha Tau Medical - Craft
Alpha Tau Medical has 5 employees across 2 locations and $55 m in total funding,. See insights on Alpha Tau Medical including office locations, competitors, revenue, financials, executives, …See details»
Alpha Tau Medical - Israeli Startup | Startup Nation Finder
Dec 27, 2017 Alpha Tau is a medical device company that focuses on the development and commercialization of its Diffusing Alpha-emitters Radiation Therapy (DaRT) for the treatment …See details»
Alpha Tau Medical Announces Full Year 2023 Financial Results and ...
- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial currently …See details»
Alpha Tau Medical Company Overview, Contact Details
Mar 20, 2022 | www.alphatau.com. Alpha Tau Medical Ltd. received award Breakthrough Device Designation for Alpha DaRT on Oct 8th '21. Alpha Tau Medical, the developer of the …See details»
Alpha Tau Medical Announces Full Year 2022 Financial Results and ...
Mar 9, 2023 In 2023, we are focused on conducting our ReSTART trial, clinically examining the treatment of internal organ tumors with high unmet need, including pancreatic and liver …See details»
Alpha Tau Announces Acceptance Into FDA’s Total Product
JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters …See details»
Alpha Tau Announces Acceptance Into FDA’s Total Product Life …
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeSee details»
Alpha Tau Medical Announces Full Year 2022 Financial Results and ...
- Opened U.S. pivotal trial in recurrent cutaneous squamous cell carcinoma, which began enrolling patients in March -- Received Health Canada approval to initiate a liver cancer …See details»
Alpha Tau Medical Announces Second Quarter 2024 Financial …
Aug 14, 2024 Alpha Tau Medical Ltd. - First patient treated in May for liver metastases from colorectal cancer - - Publication in June in Cancers journal of long-term safety and efficacy …See details»
Alpha Tau Medical | CipherBio
Explore Alpha Tau Medical's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors
Jun 8, 2022 JERUSALEM, March 21, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced …See details»
Alpha Tau Announces Health Canada Authorization for Alpha
JERUSALEM, March 01, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (See details»
Recent Posts - alphatau.com
JERUSALEM, December 18th, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy …See details»
Alpha Tau Treats First Patient with Recurrent Lung Cancer
JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd.See details»
Events & Presentation - alphatau
Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference . New York City, USA . September 26, 2024See details»